Literature DB >> 7446316

Modulation of the immune system in the mouse. 1. Drug administration prior to antigen sensitization.

J Cottney, J Bruin, A J Lewis.   

Abstract

A model has been developed in the mouse in which methylated bovine serum albumin (MBSA) and sheep red blood cells have been used to produce delayed type hypersensitivity (DTH) and humoral immunity (HI), respectively. The time course between antigen sensitization and challenge was chosen such that cyclophosphamide (CY), administered prior to sensitization, produced DTH enhancement and also produced suppression of HI when administered at high doses. A number of other drugs have been examined in this model but only CY-like drugs, viz. alkylating agents, produced similar DTH enhancement. DTH was suppressed in a few cases. The HI response was enhanced or suppressed by a number of unrelated drugs. CY was the only alkylating agent to suppress the antibody titre. The mechanisms for these drug effects are uncertain. However, a number of drugs elicit effects on either DTH or HI which suggests there is selective removal of certain cell populations rather than non-specific cytotoxicity. Possible theories for the effects observed are discussed. These studies also suggest that CY possesses unique properties in this particular model.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7446316     DOI: 10.1007/bf01971444

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  28 in total

Review 1.  Selective suppression of humoral immunity by antineoplastic drugs.

Authors:  G H Heppner; P Calabresi
Journal:  Annu Rev Pharmacol Toxicol       Date:  1976       Impact factor: 13.820

2.  Destruction and regeneration of lymphocyte populations in the mouse spleen after cyclophosphamide treatment.

Authors:  F Dumont
Journal:  Int Arch Allergy Appl Immunol       Date:  1974

3.  Influence of cyclophosphamide on the delayed hypersensitivity in the mouse after intraperitoneal immunization.

Authors:  J A Kerckhaert
Journal:  Ann Immunol (Paris)       Date:  1974-06

4.  Regulation of homocytotropic antibody formation in the rat. IV. Effects of various immunosuppressive drugs.

Authors:  M Taniguchi; T Tada
Journal:  J Immunol       Date:  1971-08       Impact factor: 5.422

5.  Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide.

Authors:  J L Turk; D Parker; L W Poulter
Journal:  Immunology       Date:  1972-10       Impact factor: 7.397

6.  Differential effects of cyclophosphamide on the B and T cell compartments of adult mice.

Authors:  G D Stockman; L R Heim; M A South; J J Trentin
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

7.  Hematopoietic recovery after large doses of cyclophosphamide: correlation of proliferative state with sensitivity.

Authors:  W D DeWys; A Goldin; N El
Journal:  Cancer Res       Date:  1970-06       Impact factor: 12.701

8.  Regulation of delayed-type hypersensitivity. III. Effect of cyclophosphamide on the suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice.

Authors:  H K Gill; F Y Liew
Journal:  Eur J Immunol       Date:  1978-03       Impact factor: 5.532

9.  Further studies on B-lymphocyte suppression in delayed hypersensitivity, indicating a possible mechanism for Jones-Mote hypersensitivity.

Authors:  J L Turk; D Parker
Journal:  Immunology       Date:  1973-04       Impact factor: 7.397

10.  Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.

Authors:  P W Askenase; B J Hayden; R K Gershon
Journal:  J Exp Med       Date:  1975-03-01       Impact factor: 14.307

View more
  4 in total

1.  Immunotherapy of equine cutaneous lymphosarcome using low dose cyclophosphamide and autologous tumor cells infected with vaccinea virus.

Authors:  R D Gollagher; B Ziola; B J Chelack; D M Haines
Journal:  Can Vet J       Date:  1993-06       Impact factor: 1.008

2.  Relationship between delayed hypersensitivity response and acquired cell-mediated immunity in C57BL/6J mice infected with Leishmania donovani.

Authors:  J R Fahey; R Herman
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

3.  Modulation of the immune system in the mouse. 2. Drug administration following antigen sensitization.

Authors:  J Cottney; J Bruin; A J Lewis
Journal:  Agents Actions       Date:  1980-04

4.  Long-lasting enhancement of the delayed-type hypersensitivity response to heterologous erythrocytes in mice after a single injection of cyclophosphamide.

Authors:  D H Bovbjerg; R Ader; N Cohen
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.